UnknownNot Applicable

Monitoring and Evaluation Study of Project ECHO for ILD

United States200 participantsStarted 2022-07

Plain-language summary

The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pulmonologists and primary care physicians who participate in Project ECHO for ILD. Exclusion Criteria: \-

What they're measuring

Impact on procedural knowledge

Timeframe: Up to 18 months

Impact on local care utilization

Timeframe: Up to 18 months

Trial details

NCT IDNCT05455437

SponsorPulmonary Care and Research Collaborative Limited

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12

View on ClinicalTrials.gov More Interstitial Lung Diseases trials